 |
|
Herpes zoster infection in patients with inflammatory bowel disease
Dong Hyun Kim, Sang-Bum Kang
Korean J Intern Med. 2025;40(3):347-356. Published online 2025 Apr 30 DOI: https://doi.org/10.3904/kjim.2024.342
|
|
Citations to this article as recorded by
 Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective
Shintaro Akiyama
Intestinal Research.2026; 24(2): 197. CrossRef Ultrasound‐Guided Liposomal vs. Conventional Bupivacaine Erector Spinae Plane Block Plus Gabapentin for Postherpetic Neuralgia
Xia‐Jing Xu, Li‐Juan Liu, Fa‐Ming Xu, Xiang‐Yu Fang
The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety
Yoon Suk Jung
Intestinal Research.2026; 24(2): 193. CrossRef Herpes zoster in inflammatory bowel disease: pathogenesis, therapy-related risks, and prevention strategies
Guiqin Wu, Ting Xiang, Wenxin Wang, Qing Zhou
The Egyptian Journal of Internal Medicine.2026;[Epub] CrossRef
|